1,3,7,9-Tetramethyl-7,9-dihydro-1H-purine-2,6,8(3H)-trione(CAS: 2309-49-1)

1,3,7,9-Tetramethyl-7,9-dihydro-1H-purine-2,6,8(3H)-trione (CAS: 2309-49-1) is regulated under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), which includes hazard communication and labeling requirements. In the European Union, it falls under the REACH regulation, requiring registration and assessment of substances. For FDA and EPA, it is classified based on toxicity and environmental impact, with specific reporting and handling requirements as per the hazardous waste regulations.

1,3,7,9-Tetramethyl-7,9-dihydro-1H-purine-2,6,8(3H)-trione (CAS: 2309-49-1) can be synthesized using alternative reagents such as methyl isocyanate or methyl isothiocyanate. Other analogs like 2-aminopurine or 6-mercaptopurine can be used as substitutes, depending on the specific application. These alternatives can offer similar functionalities in various chemical reactions.

The market for 1,3,7,9-Tetramethyl-7,9-dihydro-1H-purine-2,6,8(3H)-trione (CAS: 2309-49-1) is primarily driven by its use in pharmaceuticals, particularly in the development of antiviral and antifungal drugs. Research trends focus on its potential as an antiviral agent against RNA viruses. Market trends indicate increasing demand in the pharmaceutical sector, with ongoing studies exploring its efficacy and potential as a broad-spectrum antiviral.

Waste containing 1,3,7,9-Tetramethyl-7,9-dihydro-1H-purine-2,6,8(3H)-trione (CAS: 2309-49-1) should be collected in appropriate labeled containers and handled by trained individuals. Proper waste disposal methods include incineration or professional waste disposal services. Environmental protection measures include minimizing waste generation and ensuring that waste is treated to prevent environmental contamination. Regulatory compliance is essential, with adherence to local hazardous waste regulations and guidelines.